Meg Tirrell joined CNBC in April 2014 as a general assignment reporter focusing on biotechnology and pharmaceuticals. She appears on CNBC's Business Day programming, contributes to CNBC.com and is based at the network's global headquarters in Englewood Cliffs, N.J.
Prior to joining CNBC, she led coverage of the biotechnology industry for Bloomberg News. She broke news on proxy fights, mergers and acquisitions, and drug development, and wrote features that illuminate how science and business meet. She also contributed to Bloomberg Television and Bloomberg Businessweek.
She holds a master's degree in journalism from Northwestern University and a bachelor's degree in English and music from Wellesley College.
Follow her on Twitter @megtirrell.
Les Funtleyder, E Squared Asset Management, and CNBC's Meg Tirrell, discuss whether there is more pain to come in biotech and if the pullback presents a buying opportunity.
CNBC's Eamon Javers reports on government involvement in drug prices.
While Martin Shkreli said little in court, his expressions and activity on Twitter spoke volumes. CNBC's Meg Tirrell reports, Henry Blodget of Business Insider joins the discussion.
Former Turing Pharmaceuticals CEO Martin Shkreli was escorted from a drug price hike hearing after pleading the Fifth Amendment. CNBC's Meg Tirrell reports on comments by Rep. John Duncan (R-Tenn.) on Shkreli's what he calls "arrogance."
CNBC's Meg Tirrell reports from Capitol Hill, where former Turing Pharmaceuticals CEO Martin Shkreli's invoked the Fifth Amendment at a drug price hike hearing.
Former Turing Pharmaceuticals executive Martin Shkreli will appear before Congress this morning, reports CNBC's Meg Tirrell.
CNBC's Meg Tirrell reports from Brooklyn on Martin Shkreli's hearing.
CNBC's Meg Tirrell reports the details behind the first Zika virus case being acquired sexually.